Evidence map›Paper›PMID 42830375›Full record

ArticleJournal of natural medicines2026

The endophyte secondary metabolite phenazine-1-carboxylic acid promotes tanshinone biosynthesis in Salvia miltiorrhiza callus.

Miho Hamai, Anju Ishii, Nozomi Sakamoto, Hiroki Fujioka, Junko Tsukioka, Tomoe Ohta, Seikou Nakamura, Takahiro Matsumoto

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of natural medicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Miho HamaiKyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto, 607-8412, Japan.
Anju IshiiKyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto, 607-8412, Japan.
Nozomi SakamotoKyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto, 607-8412, Japan.
Hiroki FujiokaKyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto, 607-8412, Japan.
Junko TsukiokaKyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto, 607-8412, Japan.
Tomoe OhtaKyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto, 607-8412, Japan.
Seikou NakamuraKyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto, 607-8412, Japan.
Takahiro MatsumotoKyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto, 607-8412, Japan. tmatsumo@mb.kyoto-phu.ac.jp.ORCID http://orcid.org/0000-0003-2408-669X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Salvia miltiorrhiza is a traditional medicinal plant widely used to treat cardiovascular and cerebrovascular diseases. Tanshinones, including cryptotanshinone, a major bioactive constituent, exhibit various pharmacological activities. Therefore, methods for efficiently increasing tanshinone production are urgently needed. Recently, plant endophytes have attracted considerable attention as novel elicitors that promote the production of valuable bioactive compounds. In the present study, we investigated the effects of secondary metabolites produced by endophytes on the biosynthesis and accumulation of tanshinones in S. miltiorrhiza. Pseudomonas chlororaphis KPUPH-SMC was identified as an endophyte capable of promoting tanshinone production, and phenazine-1-carboxylic acid (PCA) was identified as the metabolite responsible for this activity. Our transcriptome analysis further demonstrated that PCA significantly upregulated the gene expression of tanshinone biosynthetic enzymes (GGPS, CPS, and KSL1). These findings suggest that endophyte-derived secondary metabolites can be used to enhance the biosynthesis of valuable compounds in medicinal plants. This approach represents a promising strategy to improve the quality of herbal medicines.

Indexed as

Biosynthesis of tanshinonesEndophytesSalvia miltiorrhizaSecondary metabolismTanshinone

Identifiers

PMID42830375

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.